Results 141 to 150 of about 395,238 (233)

Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]

Ther Adv Vaccines Immunother, 2022
Otiv M, Botre A, Shah P.
europepmc   +1 more source

Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]

Cureus
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc   +1 more source

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]

Public Health Pract (Oxf), 2023
Guo A, Leung J, Ayers T, Fields VS, Safi H, Waters C, Curns AT, Routh JA, Haselow DT, Marlow MA, Marin M.   +10 more
europepmc   +1 more source

High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. [PDF]

PLOS Glob Public Health
Prosperi C, Truelove S, Carcelen AC, Chongwe G, Mwansa FD, Ndubani P, Simulundu E, Bwalya IC, Hamahuwa M, Kapungu K, Matakala KH, Musukwa G, Mutale I, Betha E, Chaavwa N, Kampamba L, Matoba J, Munachoonga P, Mufwambi W, Situtu K, Thuma PE, Sakala C, Kayeye P, Winter AK, Ferrari MJ, Moss WJ, Mutembo S.   +26 more
europepmc   +1 more source

Corrigendum to "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo" [Vaccine: X 9 (2021) 100127]. [PDF]

Vaccine X, 2022
Cheng A, Frey K, Mwamba GN, McCarthy KA, Hoff NA, Rimoin AW.   +5 more
europepmc   +1 more source

Strategies and Challenges Involved in the Eradication of Rubella; Justification for Inclusion of Rubella Vaccine in Nigeria’s National Program on Immunization

, 2002
for presentation held at the Conference of the Medical Women’s Association in Lagos, Nigeria on March 8, 2002.Rubella is also known as German measles. Rubella is caused by a togavirus which spreads by droplet infection.
Obilade, Titilola T.
core  

Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055. [PDF]

MMWR Morb Mortal Wkly Rep
Lebo E, Vynnycky E, Alexander JP, Ferrari MJ, Winter AK, Frey K, Papadopoulos T, Grant GB, O'Connor P, Reef SE, Crowcroft NS, Zimmerman LA.   +11 more
europepmc   +1 more source

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo. [PDF]

Vaccine X, 2021
Cheng A, Frey K, Mwamba GN, McCarthy KA, Hoff NA, Rimoin AW.   +5 more
europepmc   +1 more source

Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]

Med Devices (Auckl)
Ratta BS, Naik A, Mutha S.
europepmc   +1 more source

Prediction of Specific Antibody- and Cell-Mediated Responses Using Baseline Immune Status Parameters of Individuals Received Measles-Mumps-Rubella Vaccine. [PDF]

Viruses, 2023
Toptygina A, Grebennikov D, Bocharov G.
europepmc   +1 more source